These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6793070)

  • 1. Competition between erythromycin and virginiamycin for in vitro binding to the large ribosomal subunit.
    Parfait R; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1981 Jul; 654(2):236-41. PubMed ID: 6793070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence stopped flow analysis of the interaction of virginiamycin components and erythromycin with bacterial ribosomes.
    Moureau P; Engelborghs Y; Di Giambattista M; Cocito C
    J Biol Chem; 1983 Dec; 258(23):14233-8. PubMed ID: 6417137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of the binding of virginiamycin S to Escherichia coli ribosomes.
    de Bethune MP; Nierhaus KH
    Eur J Biochem; 1978 May; 86(1):187-91. PubMed ID: 95947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vitro binding of virginiamycin M to bacteria ribosomes and ribosomal subunits.
    Cocito C; Di Giambattista M
    Mol Gen Genet; 1978 Oct; 166(1):53-9. PubMed ID: 105240
    [No Abstract]   [Full Text] [Related]  

  • 5. A spectrofluorimetric study of the interaction between virginiamycin S and bacterial ribosomes.
    Parfait R; de Béthune MP; Cocito C
    Mol Gen Genet; 1978 Oct; 166(1):45-51. PubMed ID: 105239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Action of ions and pH on the binding of virginiamycin S to ribosomes.
    Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1983 May; 757(1):92-100. PubMed ID: 6404307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonistic interactions of macrolides and synergimycins on bacterial ribosomes.
    Di Giambattista M; Vannuffel P; Sunazuka T; Jacob T; Omura S; Cocito C
    J Antimicrob Chemother; 1986 Sep; 18(3):307-15. PubMed ID: 3095298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of 50 S-binding antibiotics to characterize the ribosomal site to which peptidyl-tRNA is bound.
    Odom OW; Hardesty B
    J Biol Chem; 1992 Sep; 267(27):19117-22. PubMed ID: 1527036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance.
    Tu D; Blaha G; Moore PB; Steitz TA
    Cell; 2005 Apr; 121(2):257-70. PubMed ID: 15851032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of virginiamycin S binding site on bacterial ribosome by fluorescence energy transfer.
    Di Giambattista M; Thielen AP; Maassen JA; Möller W; Cocito C
    Biochemistry; 1986 Jun; 25(12):3540-7. PubMed ID: 3087416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of fluorescence quenching of ribosome-bound virginiamycin S.
    Di Giambattista M; Ide G; Engelborghs Y; Cocito C
    J Biol Chem; 1984 May; 259(10):6334-9. PubMed ID: 6427212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of binding of macrolides, lincosamides, and synergimycins to ribosomes.
    Di Giambattista M; Engelborghs Y; Nyssen E; Cocito C
    J Biol Chem; 1987 Jun; 262(18):8591-7. PubMed ID: 3110150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lasting damage to bacterial ribosomes by reversibly bound virginiamycin M.
    Parfait R; Cocito C
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5492-6. PubMed ID: 6776538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity labeling of the virginiamycin S binding site on bacterial ribosome.
    Di Giambattista M; Nyssen E; Pecher A; Cocito C
    Biochemistry; 1990 Oct; 29(39):9203-11. PubMed ID: 2125475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinupristin (RP 57669): a new tool to investigate ribosome-group B streptogramin interactions.
    Beyer D; Vannuffel P; Pepper K
    Biol Chem; 1998 Jul; 379(7):841-6. PubMed ID: 9705147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lasting ribosome alteration produced by virginiamycin M disappears upon removal of certain ribosomal proteins.
    Moureau P; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1983 Mar; 739(2):164-72. PubMed ID: 6402016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the reversible binding of virginiamycin M to ribosome and particle functions after removal of the antibiotic.
    Nyssen E; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1989 Sep; 1009(1):39-46. PubMed ID: 2506929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action of erythromycin and virginiamycin S on polypeptide synthesis in cell-free systems.
    Chinali G; Nyssen E; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1988 Nov; 951(1):42-52. PubMed ID: 3142522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro and in vivo inactivation of ribosomes by virginiamycin M does not entail an alteration of 5, 16 and 23 S ribosomal RNA.
    Cocito C; Vanlinden F; Branlant C
    Biochim Biophys Acta; 1983 Mar; 739(2):158-63. PubMed ID: 6402015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of [14C]erythromycin to Escherichia coli ribosomes.
    Pestka S
    Antimicrob Agents Chemother; 1974 Oct; 6(4):474-8. PubMed ID: 4157348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.